Lantheus Holdings Operating Margin 2013-2025 | LNTH
Current and historical operating margin for Lantheus Holdings (LNTH) over the last 10 years. The current operating profit margin for Lantheus Holdings as of June 30, 2025 is 25.75%.
| Lantheus Holdings Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $1.52B | $0.44B | 28.80% |
| 2025-03-31 | $1.54B | $0.45B | 29.47% |
| 2024-12-31 | $1.53B | $0.46B | 29.86% |
| 2024-09-30 | $1.50B | $0.48B | 32.13% |
| 2024-06-30 | $1.44B | $0.46B | 31.92% |
| 2024-03-31 | $1.37B | $0.48B | 35.14% |
| 2023-12-31 | $1.30B | $0.36B | 28.06% |
| 2023-09-30 | $1.21B | $0.06B | 4.56% |
| 2023-06-30 | $1.13B | $0.03B | 2.58% |
| 2023-03-31 | $1.03B | $-0.03B | -3.12% |
| 2022-12-31 | $0.94B | $0.04B | 3.85% |
| 2022-09-30 | $0.80B | $0.17B | 21.57% |
| 2022-06-30 | $0.67B | $0.07B | 10.98% |
| 2022-03-31 | $0.54B | $-0.02B | -3.14% |
| 2021-12-31 | $0.43B | $-0.06B | -14.08% |
| 2021-09-30 | $0.39B | $-0.03B | -6.67% |
| 2021-06-30 | $0.38B | $-0.02B | -4.51% |
| 2021-03-31 | $0.34B | $0.00B | 1.17% |
| 2020-12-31 | $0.34B | $-0.01B | -1.47% |
| 2020-09-30 | $0.34B | $0.01B | 2.39% |
| 2020-06-30 | $0.33B | $0.02B | 6.63% |
| 2020-03-31 | $0.35B | $0.04B | 12.22% |
| 2019-12-31 | $0.35B | $0.05B | 14.94% |
| 2019-09-30 | $0.35B | $0.06B | 16.52% |
| 2019-06-30 | $0.35B | $0.06B | 18.39% |
| 2019-03-31 | $0.35B | $0.07B | 18.68% |
| 2018-12-31 | $0.34B | $0.06B | 18.60% |
| 2018-09-30 | $0.34B | $0.06B | 16.52% |
| 2018-06-30 | $0.33B | $0.05B | 16.06% |
| 2018-03-31 | $0.33B | $0.06B | 16.52% |
| 2017-12-31 | $0.33B | $0.05B | 15.71% |
| 2017-09-30 | $0.32B | $0.06B | 16.98% |
| 2017-06-30 | $0.32B | $0.06B | 17.35% |
| 2017-03-31 | $0.31B | $0.05B | 16.67% |
| 2016-12-31 | $0.30B | $0.06B | 18.94% |
| 2016-09-30 | $0.30B | $0.06B | 19.13% |
| 2016-06-30 | $0.30B | $0.06B | 19.06% |
| 2016-03-31 | $0.29B | $0.05B | 16.33% |
| 2015-12-31 | $0.29B | $0.04B | 13.99% |
| 2015-06-30 | $0.22B | $0.03B | 11.16% |
| 2015-03-31 | $0.23B | $0.03B | 13.22% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.733B | $1.534B |
| Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.889B | 27.07 |
| Boston Scientific (BSX) | United States | $156.325B | 37.28 |
| Stryker (SYK) | United States | $149.639B | 30.46 |
| EssilorLuxottica (ESLOY) | France | $141.259B | 0.00 |
| Medtronic (MDT) | Ireland | $119.046B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.750B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.937B | 25.13 |
| ResMed (RMD) | United States | $40.192B | 28.75 |
| Agilent Technologies (A) | United States | $35.696B | 23.06 |
| GE HealthCare Technologies (GEHC) | United States | $33.662B | 15.82 |
| Terumo (TRUMY) | Japan | $26.606B | 31.53 |
| Koninklijke Philips (PHG) | Netherlands | $26.557B | 17.57 |
| Insulet (PODD) | United States | $23.925B | 80.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.018B | 13.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.402B | 0.00 |
| Baxter (BAX) | United States | $12.681B | 9.80 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.061B | 29.61 |
| Envista Holdings (NVST) | United States | $3.520B | 24.63 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.349B | 14.86 |
| Perrigo (PRGO) | Ireland | $3.266B | 8.16 |
| ICU Medical (ICUI) | United States | $3.151B | 21.45 |
| Haemonetics (HAE) | United States | $2.628B | 11.73 |
| Acuren (TIC) | United States | $2.261B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.213B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.159B | 46.29 |
| QuidelOrtho (QDEL) | United States | $1.948B | 12.26 |
| Green Thumb Industries (GTBIF) | United States | $1.840B | 79.00 |
| AtriCure (ATRC) | United States | $1.838B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.519B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.503B | 17.74 |
| AdaptHealth (AHCO) | United States | $1.284B | 18.25 |
| Neogen (NEOG) | United States | $1.249B | 19.83 |
| BioLife Solutions (BLFS) | United States | $1.200B | 2505.00 |
| InMode (INMD) | Israel | $0.944B | 8.74 |
| Kestra Medical Technologies (KMTS) | United States | $0.829B | 0.00 |
| Valneva SE (VALN) | France | $0.753B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.740B | 0.00 |
| SNDL (SNDL) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.52 |
| Evolus (EOLS) | United States | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.479B | 16.50 |
| CeriBell (CBLL) | United States | $0.434B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.379B | 3.36 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.306B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Brainsway (BWAY) | Israel | $0.294B | 59.85 |
| High Tide (HITI) | Canada | $0.292B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.286B | 21.68 |
| Omeros (OMER) | United States | $0.283B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.242B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.199B | 16.63 |
| FitLife Brands (FTLF) | United States | $0.175B | 0.00 |
| Biote (BTMD) | United States | $0.170B | 5.64 |
| Jushi Holdings (JUSHF) | United States | $0.149B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.78 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 33.68 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 31.08 |
| United-Guardian (UG) | United States | $0.039B | 15.02 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Sharps Technology (STSS) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |